Comparative Pharmacology
Head-to-head clinical analysis: EVANS BLUE versus LYMPHAZURIN.
Head-to-head clinical analysis: EVANS BLUE versus LYMPHAZURIN.
EVANS BLUE vs LYMPHAZURIN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Evans Blue is a diazo dye that binds reversibly to plasma proteins, primarily albumin. Its primary utility is as a visual indicator for the estimation of blood volume or plasma volume via dye dilution technique. It also has histological applications for staining myelin sheaths and detecting blood-brain barrier disruption.
Lymphazurin is a diagnostic dye composed of isosulfan blue. It is a hydrophilic molecule that selectively binds to serum albumin and is preferentially taken up by lymphatic vessels. When injected subcutaneously or intradermally, it enters the lymphatic system and stains the lymphatic vessels and nodes, allowing for visual identification during lymph node mapping and sentinel lymph node biopsy procedures.
Adults: 0.5-1.0 mL of 0.5% solution (2.5-5 mg) IV bolus for determination of blood volume. Repeat doses must be separated by at least 1 hour due to slow clearance.
0.1 mL (100 mcg) administered via submucosal injection in 3 divided doses into the distal submucosa surrounding the cervical os (12, 4, and 8 o'clock positions) at a depth of 3 mm, 10 minutes prior to the procedure.
None Documented
None Documented
Terminal elimination half-life ranges from 2 to 12 hours, mean approximately 6 hours; prolonged in hepatic impairment or decreased albumin levels.
Terminal elimination half-life is 18–24 hours; prolonged in renal impairment (up to 40 hours in severe impairment), requiring dose adjustment.
Primarily excreted unchanged in bile (80-90%) into feces; renal elimination accounts for <5% due to high protein binding.
Primarily renal excretion as unchanged drug (approximately 70%) and as glucuronide conjugate (20%); negligible biliary or fecal elimination (<5%).
Category C
Category C
Diagnostic Dye
Diagnostic Dye